Cardinal Health Stock (CAH)

XNYS Alert Compare

Health Care · Fundamental analysis

· How we analyze

Metrics from daily candles, as of Nov 20, 2026 · Extended universe

Figures in the price bar from TradingView (mostly trailing 12 months) · our fundamental analysis uses the fiscal year

Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself. Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself. Academy: 200-day line · RSI

About the company

Cardinal Health is a major pharmaceutical wholesaler from Ohio. It supplies pharmacies, hospitals and doctors’ offices in the US with medicines and also makes medical supplies. It also provides services for specialist physicians and logistics. As of Oct 11, 2026

Fact sheet (from the annual report) Wholesale of drugs and drugstore products · Dublin, USA

Cardinal Health is a healthcare products and services company founded in 1979 and incorporated in Ohio. Its customers are hospitals, hospital networks, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients at home. The pharmaceutical division, with by far the larger share of revenue in fiscal year 2026, distributes branded, generic and specialty drugs as well as over-the-counter products in the US. The pharmaceutical margin comes from discounts, rebates and fees from generic manufacturers and from distribution fees paid by branded manufacturers, among other sources. The medical products division makes or sources private-label items and, in the US and Canada, also supplies branded products of other manufacturers to hospitals and other healthcare providers. Other areas run nuclear pharmacies, supply chronically ill patients at home and organize shipping for healthcare providers.

Automatically summarized from SEC annual report (10-K, filed Aug 11, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 15, 2026

Price performance at a glance

Last 30 trading days
  • Today +0.2%
  • 7 days −3.0%
  • 30 days +6.0%
  • 1 year +31.2%
Day range (last trading day)
−0.3%Price at 15% of the range+1.8%
52-week range
−33.9%Price at 87% of the range+4.9%
Distance from the all-time high
−4.7%

Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Fundamentals · Analysis method

Growth, margin, balance sheet, cash flow and dividend compared with the sector – with traffic lights and quality checks in the fundamental analysis. To the fundamental analysis

Fundamental analysis

Cardinal Health · Sector Health Care · amounts in USD

Source: SEC filings, As of Aug 11, 2026.

For you first Dividend

The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 9.4x.

Years without a cut
at least 10
as far as the data goes
Growth per year (5 yrs)
+1.0%
dividend per share, average per year
Coverage by free cash flow
9.4x
covered from 1.0x

For you first Valuation

The P/E is above its own median of the 5 fiscal years before.

With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation. Sign up free

For you first Growth

How strongly revenue and earnings per share have grown over the years.

Check “Growth”
7 of 7
criteria with data met
Revenue per year (5 y)
+9.4%
EPS per year (5 y)
+28.3%

For you first Quality

How much of revenue remains and whether profit arrives as cash.

Check “Quality”
1 of 7
criteria with data met
Net margin
0.7%
Cash flow ÷ profit
3.03x
backed from 1.0 · 3 years: 2.75x

For you first Trading

The overview of this stock shows the trend by timeframe.

Quality checks

Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.

Fiscal year to Jun 30, 2026

Quality 1 of 7 met · 1 without data

  • not met: Gross margin above 40% 3.8%
  • not met: Operating margin above 15% 1.0%
  • not met: Net margin above 10% 0.7%
  • no data: Return on equity above 15% negative equity
  • not met: Free cash flow margin above 10% 1.8%
  • not met: Profit in each of the last 5 fiscal years 4 of 5
  • met: Free cash flow positive in each of the last 3 fiscal years 3 of 3
  • not met: Equity ratio above 30% −5.0%
Gross margin

3.8% Fiscal year 2026

Rank 2 of 100: higher than 2% of 370 peers (All). weak.

Rank 5 of 100: higher than 5% of 49 peers (Sector). weak.

Median Health Care: 61.8%

Share of revenue left after the direct cost of the products sold.

Operating margin

1.0% Fiscal year 2026

Rank 17 of 100: higher than 17% of 470 peers (All). weak.

Rank 16 of 100: higher than 16% of 54 peers (Sector). weak.

Median Health Care: 17.0%

Operating income divided by revenue: what the core business earns before interest and taxes.

Net margin

0.7% Fiscal year 2026

Rank 14 of 100: higher than 14% of 584 peers (All). weak.

Rank 15 of 100: higher than 15% of 63 peers (Sector). weak.

Median Health Care: 12.9%

Profit after all costs, interest and taxes divided by revenue.

Return on assets

3.0% Fiscal year 2026 (total assets at year end)

Rank 34 of 100: higher than 34% of 594 peers (All). medium.

Rank 18 of 100: higher than 18% of 63 peers (Sector). weak.

Median Health Care: 6.6%

Net income divided by total assets at fiscal year end.

Equity ratio

−5.0% Fiscal year 2026

Rank 4 of 100: higher than 4% of 595 peers (All). weak.

Rank 6 of 100: higher than 6% of 63 peers (Sector). weak.

Median Health Care: 44.2%

Equity as a share of total assets. Usually low for banks.

Free cash flow margin

1.8% Fiscal year 2026

Rank 19 of 100: higher than 19% of 465 peers (All). weak.

Rank 16 of 100: higher than 16% of 61 peers (Sector). weak.

Median Health Care: 14.5%

Free cash flow divided by revenue.

Free cash flow

4.5B USD Fiscal year 2026

Operating cash flow minus capital expenditure on property and equipment.

Growth 7 of 7 met

  • met: Over 3 years, revenue grew by more than 5% per year +7.4%
  • met: Over 5 years, revenue grew by more than 5% per year +9.4%
  • met: Over 10 years, revenue grew by more than 5% per year +7.7%
  • met: Over 3 years, EPS grew by more than 5% per year +93.4%
  • met: Over 5 years, EPS grew by more than 5% per year +28.3%
  • met: Revenue rose in at least 4 of the last 5 fiscal years 4 of 5
  • met: Revenue rose in the last fiscal year +14.2%
Revenue growth 3 years

+7.4% per year

Rank 57 of 100: higher than 57% of 578 peers (All). medium.

Rank 62 of 100: higher than 62% of 62 peers (Sector). medium.

Median Health Care: +5.1%

Average growth per year over 3 fiscal years.

Revenue growth 5 years

+9.4% per year

Rank 55 of 100: higher than 55% of 549 peers (All). medium.

Rank 58 of 100: higher than 58% of 60 peers (Sector). medium.

Median Health Care: +7.8%

Average growth per year over 5 fiscal years.

Revenue growth 10 years

+7.7% per year

Rank 59 of 100: higher than 59% of 412 peers (All). medium.

Rank 33 of 100: higher than 33% of 50 peers (Sector). medium.

Median Health Care: +9.3%

Average growth per year over 10 fiscal years.

EPS growth 3 years

+93.4% per year

Rank 98 of 100: higher than 98% of 437 peers (All). strong.

Rank 95 of 100: higher than 95% of 54 peers (Sector). strong.

Median Health Care: +5.0%

Growth of earnings per share per year, adjusted for stock splits.

EPS growth 5 years

+28.3% per year

Rank 86 of 100: higher than 86% of 399 peers (All). strong.

Rank 93 of 100: higher than 93% of 47 peers (Sector). strong.

Median Health Care: +8.3%

Growth of earnings per share per year, adjusted for stock splits.

EPS growth 10 years

+5.3% per year

Rank 29 of 100: higher than 29% of 375 peers (All). weak.

Rank 29 of 100: higher than 29% of 46 peers (Sector). weak.

Median Health Care: +9.3%

Growth of earnings per share per year, adjusted for stock splits.

Dividend 7 of 7 met

  • met: Pays a dividend 2.04 USD
  • met: Payout ratio at most 60% of earnings 28%
  • met: Dividend paid in each of the last 5 fiscal years 5 of 5
  • met: Dividend per share never lowered in the last 5 fiscal years Dividend per share as filed with the SEC, including special dividends; a one-off higher prior year does not count as a cut. never
  • met: Dividend per share higher than 5 years ago +1.0%
  • met: Free cash flow per share covers the dividend 9.4x
  • met: Dividends paid over the last 5 years covered by free cash flow 17% of free cash flow
Payout ratio

28% Fiscal year 2026

Dividend per share divided by earnings per share.

Dividend growth 5 years

+1.0% per year

Rank 10 of 100: higher than 10% of 321 peers (All). weak.

Rank 15 of 100: higher than 15% of 31 peers (Sector). weak.

Median Health Care: +6.6%

Growth of the dividend per share per year.

Free cash flow coverage

9.4x Fiscal year 2026

Free cash flow per share divided by dividend per share. From 1x the dividend is covered.

Financial strength 2 of 6 met

  • not met: Piotroski F-Score at least 7 of 9 6 of 9
  • not met: Long-term debt no higher than equity negative equity
  • not met: Current assets cover current liabilities 0.88
  • not met: Positive equity −2.9B USD
  • met: In 5 years, share count up by at most 5% −19.4%
  • met: Free cash flow positive in the last fiscal year 4.5B USD
Piotroski F-Score

6 of 9 Fiscal year 2026

Rank 45 of 100: higher than 45% of 310 peers (All). medium.

Rank 38 of 100: higher than 38% of 47 peers (Sector). medium.

Median Health Care: 6.0 of 9

Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.

Debt / equity

negative equity at fiscal year end

No rank: too few peers or not computed yet.

Long-term financial debt divided by equity.

Liquidity (current ratio)

0.88 at fiscal year end

Rank 19 of 100: higher than 19% of 513 peers (All). weak.

Rank 10 of 100: higher than 10% of 63 peers (Sector). weak.

Median Health Care: 1.58

Current assets divided by current liabilities.

Change in share count

−19.4% in 5 years

Rank 90 of 100: lower than 90% of 507 peers (All). strong.

Rank 91 of 100: lower than 91% of 59 peers (Sector). strong.

Median Health Care: −4.3%

Change in diluted share count. Negative = share buybacks, positive = new shares.

The 9 criteria of the Piotroski F-Score
  • met: Profit in the last fiscal year (positive return on assets)
  • met: Positive operating cash flow
  • not met: Return on assets higher than the prior year
  • met: Operating cash flow higher than net income
  • met: Long-term debt relative to total assets fell
  • not met: Liquidity (current assets / current liabilities) rose
  • met: No additional shares (diluted share count did not rise)
  • met: Gross margin higher than the prior year
  • not met: Revenue relative to total assets higher than the prior year

Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.

Price-based criteria (P/E, dividend yield) are shown to signed-in users.

Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.

In short

  • Light green: Revenue grew over 5 years (+9.4% per year), at least as fast as the sector median.
  • Light green: Net income (total) grew over 5 years (+22.9% per year), at least as fast as the sector median; per share +28.3% per year.
  • Light yellow: Net margin 0.7%, below the sector median (13.9%).
  • Light red: Profit in 8 of 10 fiscal years.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2017 (Jul 1, 2016 – Jun 30, 2017): Revenue 130.0B USD · Net income 1.3B USD · Net margin 1.0%
  2. Fiscal year 2018 (Jul 1, 2017 – Jun 30, 2018): Revenue 136.8B USD · Net income 256.0M USD · Net margin 0.2%
  3. Fiscal year 2019 (Jul 1, 2018 – Jun 30, 2019): Revenue 145.5B USD · Net income 1.4B USD · Net margin 0.9%
  4. Fiscal year 2020 (Jul 1, 2019 – Jun 30, 2020): Revenue 152.9B USD · Net income −3.7B USD · Net margin −2.4%
  5. Fiscal year 2021 (Jul 1, 2020 – Jun 30, 2021): Revenue 162.5B USD · Net income 611.0M USD · Net margin 0.4%
  6. Fiscal year 2022 (Jul 1, 2021 – Jun 30, 2022): Revenue 181.4B USD · Net income −933.0M USD · Net margin −0.5%
  7. Fiscal year 2023 (Jul 1, 2022 – Jun 30, 2023): Revenue 205.0B USD · Net income 261.0M USD · Net margin 0.1%
  8. Fiscal year 2024 (Jul 1, 2023 – Jun 30, 2024): Revenue 226.8B USD · Net income 852.0M USD · Net margin 0.4%
  9. Fiscal year 2025 (Jul 1, 2024 – Jun 30, 2025): Revenue 222.6B USD · Net income 1.6B USD · Net margin 0.7%
  10. Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Revenue 254.2B USD · Net income 1.7B USD · Net margin 0.7%

Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Revenue 254.2B USD · Net income 1.7B USD · Net margin 0.7%

How has it gone since the last annual report?

Trailing 12 months and quarters

Revenue in the quarter to Sep 2026 +5.5% vs. the same quarter a year earlier.

Revenue 12 months vs. prior 12
+10.0%
12 months: 257.8B USD · Fiscal year 2026: +14.2%
Net margin 12 months
0.7%
Fiscal year 2026: 0.7%
Free cash flow margin 12 months
1.9%
Fiscal year 2026: 1.8%
More depth

Calculation of the 12 months to Sep 30, 2026

  • Revenue: fiscal year to Jun 30, 2026 254.2B USD + year to date to Sep 30, 2026 67.5B USD − same period a year earlier to Sep 30, 2025 64.0B USD = 257.8B USD
  • Net income: fiscal year to Jun 30, 2026 1.7B USD + year to date to Sep 30, 2026 554.0M USD − same period a year earlier to Sep 30, 2025 450.0M USD = 1.8B USD
  • Operating cash flow: fiscal year to Jun 30, 2026 5.2B USD + year to date to Sep 30, 2026 1.4B USD − same period a year earlier to Sep 30, 2025 973.0M USD = 5.6B USD
  • Capital expenditure: fiscal year to Jun 30, 2026 649.0M USD + year to date to Sep 30, 2026 157.0M USD − same period a year earlier to Sep 30, 2025 108.0M USD = 698.0M USD
By quarter (latest first, amounts in USD)
QuarterRevenuevs. year agoNet incomeMargin
Jul–Sep 2667.5B+5.5%554.0M0.8%
Oct–Dec 2565.6B+18.8%467.0M0.7%
Jul–Sep 2564.0B+22.4%450.0M0.7%
Apr–Jun 25*60.2B+0.8%239.0M0.4%
Jan–Mar 2554.9B−0.1%506.0M0.9%
Oct–Dec 24²55.3B−3.8%400.0M0.7%
Jul–Sep 24²52.3B−4.5%416.0M0.8%
Apr–Jun 24*59.7B+11.7%236.0M0.4%

Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.

Each quarter is compared with the same quarter a year earlier.

* derived: fiscal year minus the first 9 months.

² Year-ago quarter restated after a spin-off or divestiture – compared with the restated figure from the same report.

As of: 12 months to Sep 30, 2026, filed on Nov 5, 2026 · Source: SEC filings (10-Q, 10-K)

Does the profit arrive as cash?

Earnings quality

Profit is backed by cash; interest is well covered.

Cash flow ÷ profit
3.03x
backed from 1.0 · 3 years: 2.75x
Interest coverage
7.5x
well covered from 5 · 3 years: 10.0x
Tax rate
21.6%
for information only · 3 years: 24.6%
More depth

Calculation for fiscal year 2026

  • Operating cash flow 5.2B USD ÷ group profit incl. minority interests 1.7B USD = 3.03x
  • Operating income 2.6B USD ÷ Interest expense 348.0M USD = 7.5x
  • Taxes 469.0M USD ÷ profit before tax 2.2B USD = 21.6%
By fiscal year
FYCash flow ÷ profitInterest coverageTax rate
20263.03x7.5x21.6%
20251.53x10.6x25.3%
20244.41x24.4x29.0%
2023over 10x7.8x58.9%
2022–negative–

How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.

Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.

As of fiscal year 2026 · Source: SEC filings

How even were the last years?

Consistency

In 10 fiscal years 2 loss years and one year with lower revenue.

Loss years
2 of 10
net income below zero
Years with lower revenue
1 of 10
revenue below the prior year
Net margin range
3.4 percentage points
from −2.4% to 1.0%
Net margin by fiscal year · ▾ revenue below the prior year
More depth
By fiscal year
FYRevenue vs. prior yearNet margin
2026+14.2%0.7%
2025−1.9%0.7%
2024+10.6%0.4%
2023+13.0%0.1%
2022+11.6%−0.5%
2021+6.2%0.4%
2020+5.1%−2.4%
2019+6.4%0.9%
2018+5.3%0.2%
2017+6.9%1.0%

Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.

As of fiscal years 2017–2026 · Source: SEC filings

Figures over time

Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.

Money flow in fiscal year 2026

Of 100 USD of revenue, 3.8 USD gross profit, 1.0 USD operating income and 0.7 USD net income remained.

Money flow as a table
Fiscal year 2026, amounts in USD, share of revenue
ItemAmountof revenue
Revenue254.2B USD100.0%
Gross profit9.8B USD3.8%
Cost of revenue244.5B USD96.2%
Operating income2.6B USD1.0%
Operating expenses7.2B USD2.8%
Net income1.7B USD0.7%
Interest expense348.0M USD0.1%
Taxes469.0M USD0.2%
Other82.0M USD0.0%

Taxes, interest and other items are not available separately in the SEC data; they are combined as the difference.

Margins

The operating margin stayed roughly the same in 5 years (1.0%).

Gross marginOperating marginNet margin
  1. Fiscal year 2017: Gross margin 5.0% · Operating margin 1.6% · Net margin 1.0%
  2. Fiscal year 2018: Gross margin 5.2% · Operating margin 0.1% · Net margin 0.2%
  3. Fiscal year 2019: Gross margin 4.7% · Operating margin 1.4% · Net margin 0.9%
  4. Fiscal year 2020: Gross margin 4.5% · Operating margin −2.7% · Net margin −2.4%
  5. Fiscal year 2021: Gross margin 4.2% · Operating margin 0.3% · Net margin 0.4%
  6. Fiscal year 2022: Gross margin 3.6% · Operating margin −0.3% · Net margin −0.5%
  7. Fiscal year 2023: Gross margin 3.4% · Operating margin 0.4% · Net margin 0.1%
  8. Fiscal year 2024: Gross margin 3.3% · Operating margin 0.5% · Net margin 0.4%
  9. Fiscal year 2025: Gross margin 3.7% · Operating margin 1.0% · Net margin 0.7%
  10. Fiscal year 2026: Gross margin 3.8% · Operating margin 1.0% · Net margin 0.7%

Returns

Return on equity rose in 2 years from 18.9% to 21.5%.

Return on equityReturn on assets Return on equity hidden where equity is below 5% of total assets.
  1. Fiscal year 2017: Return on equity 18.9% · Return on assets 3.2%
  2. Fiscal year 2018: Return on equity 4.2% · Return on assets 0.6%
  3. Fiscal year 2019: Return on equity 21.5% · Return on assets 3.3%
  4. Fiscal year 2020: Return on equity not available · Return on assets −9.1%
  5. Fiscal year 2021: Return on equity not available · Return on assets 1.4%
  6. Fiscal year 2022: Return on equity not available · Return on assets −2.1%
  7. Fiscal year 2023: Return on equity not available · Return on assets 0.6%
  8. Fiscal year 2024: Return on equity not available · Return on assets 1.9%
  9. Fiscal year 2025: Return on equity not available · Return on assets 2.9%
  10. Fiscal year 2026: Return on equity not available · Return on assets 3.0%

Equity and long-term debt

The equity ratio fell in 5 years from 4.0% to −5.0%.

EquityLong-term debt in USD Long-term debt, depending on the filing, includes the current portion or leases.
  1. Fiscal year 2017: Equity 6.8B USD · Long-term debt 9.1B USD
  2. Fiscal year 2018: Equity 6.1B USD · Long-term debt 8.0B USD
  3. Fiscal year 2019: Equity 6.3B USD · Long-term debt 7.6B USD
  4. Fiscal year 2020: Equity 1.8B USD · Long-term debt 6.8B USD
  5. Fiscal year 2021: Equity 1.8B USD · Long-term debt 5.4B USD
  6. Fiscal year 2022: Equity −709.0M USD · Long-term debt 4.7B USD
  7. Fiscal year 2023: Equity −2.9B USD · Long-term debt 3.9B USD
  8. Fiscal year 2024: Equity −3.2B USD · Long-term debt 4.7B USD
  9. Fiscal year 2025: Equity −2.8B USD · Long-term debt 8.0B USD
  10. Fiscal year 2026: Equity −2.9B USD · Long-term debt 7.0B USD

Liquidity (current ratio)

The current ratio fell in 5 years from 1.12 to 0.88.

Current ratio
  1. Fiscal year 2017: Current ratio 1.34
  2. Fiscal year 2018: Current ratio 1.07
  3. Fiscal year 2019: Current ratio 1.07
  4. Fiscal year 2020: Current ratio 1.10
  5. Fiscal year 2021: Current ratio 1.12
  6. Fiscal year 2022: Current ratio 1.08
  7. Fiscal year 2023: Current ratio 1.00
  8. Fiscal year 2024: Current ratio 0.98
  9. Fiscal year 2025: Current ratio 0.94
  10. Fiscal year 2026: Current ratio 0.88

Cash flow

Free cash flow rose in 5 years from 2.0B USD to 4.5B USD.

Operating cash flowCapital expenditureFree cash flow in USD
  1. Fiscal year 2017: Operating cash flow 1.2B USD · Capital expenditure 387.0M USD · Free cash flow 797.0M USD
  2. Fiscal year 2018: Operating cash flow 2.8B USD · Capital expenditure 384.0M USD · Free cash flow 2.4B USD
  3. Fiscal year 2019: Operating cash flow 2.7B USD · Capital expenditure 328.0M USD · Free cash flow 2.4B USD
  4. Fiscal year 2020: Operating cash flow 2.0B USD · Capital expenditure 375.0M USD · Free cash flow 1.6B USD
  5. Fiscal year 2021: Operating cash flow 2.4B USD · Capital expenditure 400.0M USD · Free cash flow 2.0B USD
  6. Fiscal year 2022: Operating cash flow 3.1B USD · Capital expenditure 387.0M USD · Free cash flow 2.7B USD
  7. Fiscal year 2023: Operating cash flow 2.8B USD · Capital expenditure 481.0M USD · Free cash flow 2.4B USD
  8. Fiscal year 2024: Operating cash flow 3.8B USD · Capital expenditure 511.0M USD · Free cash flow 3.3B USD
  9. Fiscal year 2025: Operating cash flow 2.4B USD · Capital expenditure 547.0M USD · Free cash flow 1.9B USD
  10. Fiscal year 2026: Operating cash flow 5.2B USD · Capital expenditure 649.0M USD · Free cash flow 4.5B USD

Share count

The share count fell in 5 years by 19.4% (mostly through share repurchases).

Diluted share count
  1. Fiscal year 2017: Diluted share count 320.0M
  2. Fiscal year 2018: Diluted share count 315.0M
  3. Fiscal year 2019: Diluted share count 301.0M
  4. Fiscal year 2020: Diluted share count 293.0M
  5. Fiscal year 2021: Diluted share count 294.0M
  6. Fiscal year 2022: Diluted share count 279.0M
  7. Fiscal year 2023: Diluted share count 262.0M
  8. Fiscal year 2024: Diluted share count 247.0M
  9. Fiscal year 2025: Diluted share count 242.0M
  10. Fiscal year 2026: Diluted share count 237.0M

From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.

Metrics chart

Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.

Metrics, up to 3 – to switch, deselect one first

Premium Line of a second stock for comparison

Net margin

The net margin stayed roughly the same in 5 years (0.7%).

CAH Sector today 13.2% Mark in the latest year: today’s median of the Health Care sector as in the sector comparison (each latest fiscal year). We do not have earlier medians.
  1. Fiscal year 2017: CAH 1.0%
  2. Fiscal year 2018: CAH 0.2%
  3. Fiscal year 2019: CAH 0.9%
  4. Fiscal year 2020: CAH −2.4%
  5. Fiscal year 2021: CAH 0.4%
  6. Fiscal year 2022: CAH −0.5%
  7. Fiscal year 2023: CAH 0.1%
  8. Fiscal year 2024: CAH 0.4%
  9. Fiscal year 2025: CAH 0.7%
  10. Fiscal year 2026: CAH 0.7% · Sector today 13.2%

Return on equity

Return on equity rose in 2 years from 18.9% to 21.5%.

CAH Sector today 14.3%
  1. Fiscal year 2017: CAH 18.9%
  2. Fiscal year 2018: CAH 4.2%
  3. Fiscal year 2019: CAH 21.5%
  4. Fiscal year 2020: CAH not available
  5. Fiscal year 2021: CAH not available
  6. Fiscal year 2022: CAH not available
  7. Fiscal year 2023: CAH not available
  8. Fiscal year 2024: CAH not available
  9. Fiscal year 2025: CAH not available
  10. Fiscal year 2026: CAH not available · Sector today 14.3%

Free cash flow margin

The free cash flow margin stayed roughly the same in 5 years (1.8%).

CAH Sector today 14.7%
  1. Fiscal year 2017: CAH 0.6%
  2. Fiscal year 2018: CAH 1.7%
  3. Fiscal year 2019: CAH 1.6%
  4. Fiscal year 2020: CAH 1.0%
  5. Fiscal year 2021: CAH 1.2%
  6. Fiscal year 2022: CAH 1.5%
  7. Fiscal year 2023: CAH 1.2%
  8. Fiscal year 2024: CAH 1.4%
  9. Fiscal year 2025: CAH 0.8%
  10. Fiscal year 2026: CAH 1.8% · Sector today 14.7%

Source: SEC filings, fiscal years up to Jun 30, 2026. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.

How reliable is the dividend?

Dividend at a glance

The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 9.4x.

Years without a cut
at least 10
as far as the data goes
Growth per year (5 yrs)
+1.0%
dividend per share, average per year
Coverage by free cash flow
9.4x
covered from 1.0x

You can see the dividend yield and shareholder yield (based on the price) with a free account. Sign up free

More depth

Calculation

  • Dividend per share: fiscal year 2021 1.94 USD → fiscal year 2026 2.04 USD = +1.0% per year
  • Free cash flow per share 19.09 USD ÷ dividend per share 2.04 USD = 9.4x

Years without a cut: in a row up to fiscal year 2026, dividend per share according to the SEC, adjusted for stock splits; only 1% less than the year before counts as a cut, also for variable dividends; a special dividend in the prior year does not. If the dividend per share falls while the total paid rises, the run ends as “unclear”. “At least” is shown only if our data ends earlier.

Shareholder yield: dividends paid plus share repurchases minus proceeds from new shares according to the cash flow statement of the last fiscal year, divided by today’s market value. Missing repurchases or new shares count as 0; without reported dividend or repurchase payments (among others for many stocks of the extended selection) there is no value. Describes the reported figures – not investment advice.

History, payout ratios and returns per year

As of fiscal year 2026 · Source: SEC filings

Valued higher or lower than usual?

Valuation against its own history

The P/E is above its own median of the 5 fiscal years before.

With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation. Sign up free

Source: SEC filings and our daily candles

Dividends and share repurchases

How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.

Dividend per share
2.04 USD · Fiscal year 2026
Dividend growth per year
3 y +1.0%5 y +1.0%10 y +2.8%
Payout ratio
of earnings 28% of free cash flow 11%
To shareholders (5 years)
8.4B USD 70% through repurchases
Share count over 5 years
−19.4% fewer shares – each share is a larger stake

Dividend per share

The dividend per share rose in 5 years from 1.94 USD to 2.04 USD.

Dividend per share USD per share Per share as filed with the SEC, including special dividends; obvious filing errors are hidden.
  1. Fiscal year 2017: Dividend per share 1.80 USD
  2. Fiscal year 2018: Dividend per share 1.85 USD
  3. Fiscal year 2019: Dividend per share 1.91 USD
  4. Fiscal year 2020: Dividend per share 1.92 USD
  5. Fiscal year 2021: Dividend per share 1.94 USD
  6. Fiscal year 2022: Dividend per share 1.96 USD
  7. Fiscal year 2023: Dividend per share 1.98 USD
  8. Fiscal year 2024: Dividend per share 2.00 USD
  9. Fiscal year 2025: Dividend per share 2.02 USD
  10. Fiscal year 2026: Dividend per share 2.04 USD

Payout ratios

The payout ratio fell in 5 years from 93.3% to 28.2%.

Payout ratio (earnings)Payout ratio (free cash flow)
  1. Fiscal year 2017: Payout ratio (earnings) 44.7% · Payout ratio (free cash flow) 72.4%
  2. Fiscal year 2018: Payout ratio (earnings) 228.4% · Payout ratio (free cash flow) 24.4%
  3. Fiscal year 2019: Payout ratio (earnings) 42.2% · Payout ratio (free cash flow) 24.1%
  4. Fiscal year 2020: Payout ratio (earnings) not available · Payout ratio (free cash flow) 35.9%
  5. Fiscal year 2021: Payout ratio (earnings) 93.3% · Payout ratio (free cash flow) 28.2%
  6. Fiscal year 2022: Payout ratio (earnings) not available · Payout ratio (free cash flow) 20.4%
  7. Fiscal year 2023: Payout ratio (earnings) 198.0% · Payout ratio (free cash flow) 22.3%
  8. Fiscal year 2024: Payout ratio (earnings) 58.0% · Payout ratio (free cash flow) 15.3%
  9. Fiscal year 2025: Payout ratio (earnings) 31.3% · Payout ratio (free cash flow) 26.7%
  10. Fiscal year 2026: Payout ratio (earnings) 28.2% · Payout ratio (free cash flow) 10.9%

What goes back to shareholders

Over 5 years, 8.4B USD went back to shareholders, 70% of it through share repurchases. That is 57% of the free cash flow of those years.

Dividends paidShare repurchasesNew shares issued (including employee plans)Free cash flow in USD
  1. Fiscal year 2017: Dividends paid 577.0M USD · Share repurchases 600.0M USD · New shares issued (including employee plans) not available · Free cash flow 797.0M USD
  2. Fiscal year 2018: Dividends paid 581.0M USD · Share repurchases 550.0M USD · New shares issued (including employee plans) not available · Free cash flow 2.4B USD
  3. Fiscal year 2019: Dividends paid 577.0M USD · Share repurchases 600.0M USD · New shares issued (including employee plans) not available · Free cash flow 2.4B USD
  4. Fiscal year 2020: Dividends paid 569.0M USD · Share repurchases 350.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.6B USD
  5. Fiscal year 2021: Dividends paid 573.0M USD · Share repurchases 200.0M USD · New shares issued (including employee plans) not available · Free cash flow 2.0B USD
  6. Fiscal year 2022: Dividends paid 559.0M USD · Share repurchases 1.0B USD · New shares issued (including employee plans) not available · Free cash flow 2.7B USD
  7. Fiscal year 2023: Dividends paid 525.0M USD · Share repurchases 2.0B USD · New shares issued (including employee plans) not available · Free cash flow 2.4B USD
  8. Fiscal year 2024: Dividends paid 499.0M USD · Share repurchases 750.0M USD · New shares issued (including employee plans) not available · Free cash flow 3.3B USD
  9. Fiscal year 2025: Dividends paid 494.0M USD · Share repurchases 765.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.9B USD
  10. Fiscal year 2026: Dividends paid 491.0M USD · Share repurchases 1.4B USD · New shares issued (including employee plans) not available · Free cash flow 4.5B USD

Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.

Valuation over time

Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.

Sector comparison

Cardinal Health next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.

Sector comparison CAH, sector Health Care; last row: sector median
Symbol Revenue (FY) Growth 5 yrsGross marginOp. marginNet marginROEEquity ratioFCF marginPiotroski
UNH UnitedHealth Group 447.6B USD +11.7%–4.2%2.7%12.0%32.3%3.6%7/9
MCK McKesson Corporation 403.4B USD +11.1%3.6%1.5%1.2%–−2.6%1.4%6/9
CVS CVS Health 402.1B USD +8.4%–1.2%0.4%2.4%29.7%1.9%7/9
CI Cigna 274.9B USD +11.4%–3.3%2.2%14.3%26.4%–7/9
CAH Cardinal Health this stock 254.2B USD +9.4%3.8%1.0%0.7%–−5.0%1.8%6/9
ELV Elevance Health 199.1B USD +10.3%–3.6%2.8%12.9%36.1%1.6%7/9
JNJ Johnson & Johnson 94.2B USD +2.7%67.9%–28.5%32.9%40.9%20.9%4/9
HCA HCA Healthcare 75.6B USD +8.0%––9.0%–−9.9%10.2%–
LLY Lilly (Eli) 65.2B USD +21.6%83.0%–31.7%77.8%23.6%13.8%7/9
Median of the sector 27 symbols 44.6B USD +8.9%67.2%17.8%13.2%14.3%38.4%14.7%7/9

Growth 5 yrs = revenue growth per year over 5 fiscal years · Op. margin = operating margin · ROE = return on equity · FCF = free cash flow · Piotroski = F-Score (only with all 9 criteria).

Compare with the closest peer in the sector CAH next to CI – quality checks, metrics and depth side by side.

Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.

Key figures with traffic lights

Each light follows a simple, disclosed rule. The comparison is with the sector median of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).

Revenue growth

Light green: above sector

+9.4% per year, last 5 years

Sector Health Care: median +8.5% (25 symbols)

What does this mean? Revenue: over 5 years it grew by 9.4% per year on average – at least as fast as the median company in the sector (+8.5%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light green: above sector

+22.9% per year, last 5 years

Sector Health Care: median +5.5% (20 symbols)

per share: +28.3% per year (5 years, split-adjusted)

What does this mean? Total net income: over 5 years it grew by 22.9% per year on average – at least as fast as the median company in the sector (+5.5%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light yellow: below sector

0.7% last fiscal year

Sector Health Care: median 13.9% (26 symbols)

What does this mean? Of every 100 USD in revenue, 0.67 USD remained as profit – less than the median company in the sector (13.9%). Five years ago the margin was 0.4%.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light gray: negative equity

– latest balance sheet

Sector Health Care: median 0.66 (19 symbols)

What does this mean? Equity is negative (e.g. due to share buybacks). A debt-to-equity ratio cannot be formed meaningfully then.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light green: covered

28% Dividend / earnings per share

Sector Health Care: median 56% (16 symbols)

What does this mean? Of every 1 USD of earnings per share, 0.28 USD went to shareholders as a dividend. The rest stays in the company. Median company in the sector: 56%.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light red: 2 loss years

8 of 10 fiscal years with a profit

What does this mean? In 8 of the last 10 fiscal years the bottom line showed a profit. 2 years ended with a loss.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
254.2B USD
Revenue vs. prior year
+14.2%
Net income (FY)
1.7B USD
Net income vs. prior year
+9.8%
EPS (FY)
7.23 USD
Superinvestors holding
3 of 26
Fiscal year to Jun 30, 2026 · 10-K filed Aug 11, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2026Jun 30, 2026 254.2B1.7B 0.7% 7.23 2.04 28%
2025Jun 30, 2025 222.6B1.6B 0.7% 6.45 2.02 31%
2024Jun 30, 2024 226.8B852.0M 0.4% 3.45 2.00 58%
2023Jun 30, 2023 205.0B261.0M 0.1% 1.00 1.98 198%
2022Jun 30, 2022 181.4B−933.0M −0.5% −3.35 1.96 –
2021Jun 30, 2021 162.5B611.0M 0.4% 2.08 1.94 93%
2020Jun 30, 2020 152.9B−3.7B −2.4% −12.61 1.92 –
2019Jun 30, 2019 145.5B1.4B 0.9% 4.53 1.91 42%
2018Jun 30, 2018 136.8B256.0M 0.2% 0.81 1.85 228%
2017Jun 30, 2017 130.0B1.3B 1.0% 4.03 1.80 45%
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q3/26Sep 30, 2026 67.5B554.0M 0.8% 2.38 0.52 22%
Q4/25Dec 31, 2025 65.6B467.0M 0.7% 1.97 0.51 26%
Q3/25Sep 30, 2025 64.0B450.0M 0.7% 1.88 0.51 27%
Q2/25*Jun 30, 2025 60.2B239.0M 0.4% – – –
Q1/25Mar 31, 2025 54.9B506.0M 0.9% 2.10 0.51 24%
Q4/24Dec 31, 2024 55.3B400.0M 0.7% 1.65 0.51 31%
Q3/24Sep 30, 2024 52.3B416.0M 0.8% 1.70 0.51 30%
Q2/24*Jun 30, 2024 59.7B236.0M 0.4% – – –
Q1/24Mar 31, 2024 54.9B258.0M 0.5% 1.07 0.50 47%
Q4/23Dec 31, 2023 57.4B353.0M 0.6% 1.50 0.50 33%
Q3/23Sep 30, 2023 54.8B5.0M 0.0% 0.02 0.50 2,503%
Q2/23*Jun 30, 2023 53.5B−64.0M −0.1% – – –

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.

Information only – does not affect the other analysis methods, not investment advice.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $00 people $0
6 months $00 people $59.6M7 people −$59.6M
12 months $00 people $61.6M8 people −$61.6M

Latest transactions

  • Aug 19, 2026 Scherer Mary C. Officer Open-market sale 2,202 shares · $522.7K · SEC
  • Aug 19, 2026 Scherer Mary C. Officer Open-market sale 100 shares · $23.7K · SEC
  • Aug 19, 2026 Hollar Jason M. Chief executive (CEO) Open-market sale 6,244 shares · $1.5M · SEC
  • Aug 19, 2026 Hollar Jason M. Chief executive (CEO) Open-market sale 16,187 shares · $3.8M · SEC
  • Aug 19, 2026 Hollar Jason M. Chief executive (CEO) Open-market sale 6,731 shares · $1.6M · SEC
  • Aug 19, 2026 Hollar Jason M. Chief executive (CEO) Open-market sale 5,704 shares · $1.3M · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Which superinvestors hold Cardinal Health?

All superinvestor portfolios

3 of 26 tracked superinvestors report a position.

Superinvestors with a position in Cardinal Health, weight in each portfolio
InvestorWeight in portfoliovs. previous quarterAs of
Renaissance Technologies 0.3% +51.9% increased Q3 2026
Bridgewater Associates 0.1% −2.8% reduced Q3 2026
Steve Cohen Point72 Asset Management < 0.1% new Q3 2026

Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

Trend score –

We do not calculate a trend score for symbols in the extended universe.

Volatility and trend strength

ADX 14 (trend strength)–
Price change 60 days–

ATR and moving averages as price values only when logged in.

More stocks from Health Care

All symbols in this sector

News

No recent news found. News is loaded automatically three times a day for trend stocks, symbols with a current Elliott setup and favorites.

Posts

No posts on CAH yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: CAH

Alerts with a free account: we send you an email as soon as the price moves above or below your level.

Checked after every data update: crypto hourly, stocks twice a day, precious metals every 4 hours on trading days, extended universe on weekdays after the close (daily candles) – not in real time.

↑ ↓ select · Enter open · Esc close